- Home
- SION vs TCMD Comparison
SION vs TCMD Comparison
Compare SION & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- TCMD
- Stock Information
- Founded
- SION 2019
- TCMD 1995
- Country
- SION United States
- TCMD United States
- Employees
- SION N/A
- TCMD N/A
- Industry
- SION
- TCMD Medical/Dental Instruments
- Sector
- SION
- TCMD Health Care
- Exchange
- SION NYSE
- TCMD Nasdaq
- Market Cap
- SION 338.0M
- TCMD 314.0M
- IPO Year
- SION 2025
- TCMD 2016
- Fundamental
- Price
- SION $11.07
- TCMD $13.33
- Analyst Decision
- SION Strong Buy
- TCMD Hold
- Analyst Count
- SION 1
- TCMD 2
- Target Price
- SION $32.00
- TCMD $18.00
- AVG Volume (30 Days)
- SION 225.5K
- TCMD 219.4K
- Earning Date
- SION 05-25-2025
- TCMD 05-05-2025
- Dividend Yield
- SION N/A
- TCMD N/A
- EPS Growth
- SION N/A
- TCMD N/A
- EPS
- SION N/A
- TCMD 0.70
- Revenue
- SION N/A
- TCMD $292,984,000.00
- Revenue This Year
- SION N/A
- TCMD $10.68
- Revenue Next Year
- SION N/A
- TCMD $8.82
- P/E Ratio
- SION N/A
- TCMD $19.04
- Revenue Growth
- SION N/A
- TCMD 6.76
- 52 Week Low
- SION $7.26
- TCMD $11.12
- 52 Week High
- SION $25.19
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- SION N/A
- TCMD 44.11
- Support Level
- SION N/A
- TCMD $13.08
- Resistance Level
- SION N/A
- TCMD $13.64
- Average True Range (ATR)
- SION 0.00
- TCMD 0.75
- MACD
- SION 0.00
- TCMD 0.08
- Stochastic Oscillator
- SION 0.00
- TCMD 53.65
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.